Kromek Group plc (KMK) Ordinary Shares 1p

Sell:6.50pBuy:6.80pNo change

Prices delayed by at least 15 minutes
Sell:6.50p
Buy:6.80p
Change:No change
Prices delayed by at least 15 minutes
Sell:6.50p
Buy:6.80p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Kromek Group plc is a developer of radiation detection and bio-detection technology solutions for the advanced imaging and chemical, biological, radiological, and nuclear (CBRN) detection segments. Its advanced imaging segment comprises the medical, security, and industrial markets. The Company provides its original equipment manufacturer customers with detector components based on its core cadmium zinc telluride (CZT) platform to detect of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings. In CBRN detection, the Company provides nuclear radiation detection solutions to the global homeland defense and security market. Its compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of dirty bombs. The Company is also developing bio-security solutions in the CBRN detection segment.

Key people

Arnab Basu
Chief Executive Officer, Executive Director
Paul N. Farquhar
Chief Financial Officer, Executive Director, Company Secretary
Albertus Beumer
Chief Operating Officer, Executive Director
Rakesh Sharma
Independent Chairman of the Board
Lawrence H. Kinet
Non-Executive Independent Director
Jerel H. Whittingham
Non-Executive Independent Director
Christopher Wilks
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    KMK
  • Location
    United Kingdom
  • Sector
    Technology
  • Industry
    Scientific & Technical Instr.
  • ISIN
    GB00BD7V5D43
  • Market cap
    £42.66m
  • Employees
    162
  • Shares in issue
    641.55m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.